Home › Funds › Convergence Investment Partners, LLC › BMY

Convergence Investment Partners, LLC position in BMY

BRISTOL-MYERS SQUIBB CO · Health Care

Convergence Investment Partners, LLC reported holding 198,050 shares of BMY (BRISTOL-MYERS SQUIBB CO) in its Q3 2026 13F filing — a position valued at US$12.4M, representing 0.92% of its reported portfolio and ranking #23 among its reported holdings. Convergence Investment Partners, LLC has disclosed BMY holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)198.05K sh
Reported value held$12.36M
Portfolio Weight0.92%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Convergence Investment Partners, LLC's BMY position evolved

Convergence Investment Partners, LLC first disclosed a stake in BMY in Q3 2023 at 9,128 shares (US$530K). The position peaked in Q3 2026 at 198,050 shares, worth US$12.4M. Across 12 filings, Convergence Investment Partners, LLC increased the stake 8 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 198,050 shares valued at US$12.4M — an increase of 27,856 shares quarter over quarter.. Notable position changes include a 63% increase in Q1 2024 (shares fell 23% over the following quarter), a 33% increase in Q3 2025 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 9.13K $530.00K New
Q4 2023 10.20K $523.00K Add
Q1 2024 16.61K $901.00K Add
Q3 2024 83.61K $4.33M New
Q4 2024 90.49K $5.12M Add
Q1 2025 76.30K $4.65M Reduce
Q2 2025 76.27K $3.53M Hold
Q3 2025 101.36K $4.57M Add
Q4 2025 112.07K $6.05M Add
Q1 2026 136.38K $8.27M Add
Q2 2026 170.19K $9.81M Add
Q3 2026 198.05K $12.36M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMY and 13F data

BMY (BRISTOL-MYERS SQUIBB CO) is a Health Care company. 26 other funds we track also report a position in BMY — the largest reported positions include Charles Schwab Investment Management (US$3.89B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$3.89B), AQR Capital Management (US$1.58B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMY

All BMY fund holders →

FAQ

How long has Convergence Investment Partners, LLC held BMY?

Convergence Investment Partners, LLC has disclosed BMY holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is Convergence Investment Partners, LLC's current position in BMY?

As of Q3 2026, Convergence Investment Partners, LLC holds 198.05K shares of BMY (BRISTOL-MYERS SQUIBB CO), valued at $12.36M, representing 0.92% of its reported portfolio and ranking #23.

Has Convergence Investment Partners, LLC been buying or selling BMY?

In the latest 13F filing (Q3 2026), Convergence Investment Partners, LLC increased its position in BMY. The position peaked in Q3 2026 at 198.05K shares.

Which other funds hold BMY?

Other major institutional holders of BMY include Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, AQR Capital Management, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.